These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 886911)

  • 1. Effects of anticholinergic and cholinesterase blocking drugs on appetitive behavior under different deprivation conditions.
    Adams PM
    Life Sci; 1977 Jul; 21(1):129-36. PubMed ID: 886911
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of cholinolytic drugs and cholinesterase blockade on deprivation based activity and appetitive behavior.
    Adams PM
    Neuropharmacology; 1973 Sep; 12(9):825-33. PubMed ID: 4746446
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of cholinergic drugs on prey-killing by rodents.
    Wnek DJ; Leaf RC
    Physiol Behav; 1973 Jun; 10(6):1107-13. PubMed ID: 4736903
    [No Abstract]   [Full Text] [Related]  

  • 5. Chin rub CRs are elicited by flavors associated with apomorphine, scopolamine, methscopolamine, physostigmine and neostigmine.
    Smith RJ; Parker LA
    Pharmacol Biochem Behav; 1985 Oct; 23(4):583-9. PubMed ID: 4070336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptual bisection in rats: the effects of physostigmine, scopolamine and pirenzepine.
    Shurtleff D; Raslear TG; Genovese RF; Simmons L
    Physiol Behav; 1992 Feb; 51(2):381-90. PubMed ID: 1557449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of one-trial passive avoidance learning in mice by scopolamine, scopolamine methylbromide, and physostigmine.
    Bohdanecký Z; Jarvik ME
    Int J Neuropharmacol; 1967 May; 6(3):217-22. PubMed ID: 6037526
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of anti-cholinergic and cholinergic drugs on habituation to motion in rats.
    Morita M; Takeda N; Hasegawa S; Yamatodani A; Wada H; Sakai S; Kubo T; Matsunaga T
    Acta Otolaryngol; 1990; 110(3-4):196-202. PubMed ID: 2239207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible role of a cholinergic system affecting hypothalamic-elicited eating.
    Stark P; Totty CW; Turk JA; Henderson JK
    Am J Physiol; 1968 Mar; 214(3):463-8. PubMed ID: 4867197
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of methscopolamine, physostigmine, and neostigmine on neuron activity in the midbrain, the hippocampus, and the hypothalamus in the behaving rat.
    Olds ME; Eibergen R
    Brain Res; 1973 Feb; 50(2):315-30. PubMed ID: 4705501
    [No Abstract]   [Full Text] [Related]  

  • 11. The cholinergic system, amnesia and memory.
    Lewis DJ; Bregman NJ
    Physiol Behav; 1972 Mar; 8(3):511-4. PubMed ID: 5064483
    [No Abstract]   [Full Text] [Related]  

  • 12. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cholinergic activity and the aversive threshold in the rat.
    Houser VP; Van Hart DA
    Pharmacol Biochem Behav; 1974; 2(5):631-7. PubMed ID: 4431827
    [No Abstract]   [Full Text] [Related]  

  • 14. Central location of a genotype-dependent cholinergic mechanism controlling exploratory behaviour in mice.
    van Abeelen JH; Smits AJ; Raaijmakers WG
    Psychopharmacologia; 1971; 19(4):324-8. PubMed ID: 5565247
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinergic modulation of spatial learning in mice in a Morris-type water maze.
    Lamberty Y; Gower AJ
    Arch Int Pharmacodyn Ther; 1991; 309():5-19. PubMed ID: 1888229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal effects of reserpine plus physostigmine and neostigmine in mice.
    Janowsky D; Pechnick R; Janowsky E
    Clin Exp Pharmacol Physiol; 1976; 3(5):483-6. PubMed ID: 975633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release.
    Janowsky DS; Risch SC; Kennedy B; Ziegler M; Huey L
    Psychopharmacology (Berl); 1986; 89(2):150-4. PubMed ID: 3088629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of scopolamine, physostigmine and chlordiazepoxide on punished and extinguished water consumption in rats.
    Miczek KA; Lau P
    Psychopharmacologia; 1975 Jun; 42(3):263-9. PubMed ID: 1161984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of physostigmine induced lethality by a combination of scopolamine and methscopolamine.
    Janowsky DS; Berkowitz A; Turken A; Risch SC
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):154-7. PubMed ID: 3993383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.